echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Three suggestions for centralized procurement to bring volume to the country

    Three suggestions for centralized procurement to bring volume to the country

    • Last Update: 2021-08-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    With the deepening of the reform of the national medical and health system, at the end of 2018, the National Medical Insurance Administration formally implemented the nationally organized drug centralized procurement and use policy.
    The national volume procurement started from the first round of the first batch (4+7), and it took less than three years.
    , Has organized five batches of six rounds of national volume procurement.
    At the regular briefing held by the State Council Information Office on the afternoon of July 8, the person in charge of the Medical Price and Bidding Purchasing Department of the National Medical Security Administration briefly summarized the five batches of centralized drug procurement.
    The overall situation of mass procurement: A total of 218 varieties are involved.
    These 218 varieties account for 30% of the purchase amount of chemical medicines from public medical institutions based on their pre-collective prices
    .


    Calculated according to the agreed purchase volume, it is estimated that the annual cost of medicines can be saved by 92.



    One, substitute

    In one fell swoop, it broke the monopoly of the original research in the market in the era of government guidance prices, and at the same time reversed the unhealthy situation of domestic drug competition
    .


    Starting from over-reviewed varieties, the original research and over-reviewed varieties form the same group of market competition, which has greatly stimulated the confidence of domestic national pharmaceutical companies in improving the quality of drugs.
    Through price-for-quantity and fair competition, companies have truly formed domestic high-quality generic drugs.
    Replacement of original research drugs


    Two, shock

    Through volume-for-price, independent quotation, and market competition, the organizer has deeply optimized the pharmaceutical industry environment and reduced the unreasonable supply chain of the circulation system.
    In particular, the fifth batch of six rounds of volume procurement has added a basis for the "Pharmaceutical Price and Recruitment" The relevant penalties in the Credit Evaluation System have further increased the cost of violations by related parties, squeezed out the cost of drug sales, and purified the practice environment for medical staff
    .

    3.
    Breakthrough

    In December 2019, the State Council’s Leading Group for Deepening the Reform of the Medical and Health System issued a notice on several policy measures to further deepen the reform of the medical and health system using centralized drug procurement and use as a breakthrough point, which emphasized the use of centralized drug procurement and use as a breakthrough point.
    The author calls it "small incision, deep breakthrough"
    .


    By means of point-by-point and round-by-point assistance, combined with the experience of Fujian Sanming's medical reform, seeking truth from facts, we will further promote the in-depth advancement of the medical reform work


    However, at the same time, there are still some problems that cannot be ignored in national volume purchases.
    The exclusive selection of relevant regions affects clinical prescription rights to a certain extent.
    Related companies use the stock market and the space of gradual price reductions.
    Prices are still relatively high, and volume purchases are still relatively high.
    The only way to get a low price is to take it.
    The path to "allowing enterprises to have reasonable profits" is difficult.
    Based on this, the author puts forward three suggestions, as follows:

    1.
    Cancel the existing rounds of elections in all provinces and change them to uniform selections in proportion to each province

    With the existing national sourcing method of selecting regions, the first-ranked company will give priority to choosing one region among the supply regions
    .


    After the priority selection is completed, starting with the first ranked company, all the companies to be selected will alternately confirm the remaining regions in order.


    Proposal: After the relevant product companies are selected, the organizer divides the selected procurement volume to the relevant companies in proportion to the winning bid order, allowing multiple companies to be selected at the same time
    .


    For example, there are 7 companies for a certain product, but only 5 companies are actually selected.


    phase



    The relevant procurement volume must be completed in full within the specified time in accordance with the relevant procurement regulations of the country
    .


    The advantage of this is to fully consider the needs of all aspects of clinical diagnosis and treatment, so that clinical patients and doctors have a certain degree of relative freedom of choice


    2.


    It is recommended to no longer keep stocks, and all purchases will be handed over to the selected varieties

    According to the national procurement policy with volume, the first-year contracted procurement volume for each variety and region is basically the actual number of selected companies in the country with 1 company, and the procurement volume is 50%; the actual number of selected companies in the country is 2, the procurement volume is 60%; the actual number of selected companies in the country is 60%; the actual number of selected companies in the country is 60%.


    If the number of selected companies is 3, the purchase volume is 70%; if the number of selected companies in the country is 4 or more, the purchase volume is 80%


    3.
    Restore the "double envelope" system

    The current national policy design for volume purchases is that, on the basis of over-assessment, the priority of all companies is to determine the short-listed enterprises and confirm the order of supply areas according to the "comparable unit price" from low to high, and the lowest "comparable unit price" is The first pick, the next lowest is the second pick, and so on to determine the other picks
    .
    If the prices are the same, choose according to options such as the price of medicines, the credit rating of recruitment and procurement, and the number of supply regions
    .
    In fact, this finalist determination still basically uses low prices as the criterion for selection
    .
    Although they are all over-rated drugs, there are still gaps between each company in terms of enterprise scale, rankings of the Ministry of Industry and Information Technology and other economic and technical standards
    .
    It is recommended that the double envelope system be restored, and the economic and technical standards and business standards are packaged together to calculate the total score.
    The technical standard score can account for 20%-30% of the comprehensive score; the price score accounts for 70%-80% of the comprehensive score
    .
    The short-listed varieties are determined based on the results of the comprehensive scoring
    .
    The reversal of the current over-evaluated price policy design has more advantages than disadvantages for encouraging companies to further accelerate independent innovation, reform and integration of pharmaceutical companies in the industry, and to further emphasize the sustainable and healthy development of companies
    .

    National procurement with volume, starting from 4+7, has been continuously improving, but how to form a reasonable, fair and just selection qualification and a benign selection price still has a long way to go
    .
    A good centralized procurement policy design should be based on the spirit of sublation, not only absorb the original essence, but also continue to accelerate innovation
    .
    Only in this way can we not deviate from the positioning and status of centralized bidding and procurement of small cuts and deep breakthroughs
    .

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.